BGM (BGM Group) Current Deferred Revenue : $0.57 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is BGM Group Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

BGM Group's current deferred revenue for the quarter that ended in Sep. 2024 was $0.57 Mil.

BGM Group Current Deferred Revenue Historical Data

The historical data trend for BGM Group's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGM Group Current Deferred Revenue Chart

BGM Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Current Deferred Revenue

Get a 7-Day Free Trial

3.93

2.84

0.68

1.11

0.57

BGM Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Current Deferred Revenue	Get a 7-Day Free Trial										0.68	2.57	1.11	0.47	0.57

BGM Group Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of BGM Group's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BGM Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BGM Group Ltd (NAS:BGM) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200

Website

https://www.bgmgroupltd.com

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.